未登录

E

Emanuelle Mamroud

Israel Institute for Biological Research

H指数:18

被引数:1,321

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

New Frontiers for Old Medications: Repurposing Approved Drugs Against Gram-Negative Bacterial Infections

IF4.2

2026-03-030

OAAI

Novel Bivalent mRNA-LNP Vaccine for Highly Effective Protection against Pneumonic Plague

新型双价mRNA-LNP疫苗，用于对肺鼠疫实现高效防护

ADVANCED SCIENCE

IF14.1

2025-04-250

OAAI

Mind the Gap-A Perspective on Strategies for Protecting against Bacterial Infections during the Period from Infection to Eradication

IF4.2

2023-06-291

OAAI

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

SCIENCE ADVANCES

IF12.5

2023-03-1036

OAAI

Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens

鼠疫耶尔森氏菌聚合F1和LcrV抗原快速诱导对肺鼠疫的保护性免疫

IF3.4

2023-03-025

OAAI

Iron-Modified Blood Culture Media Allow for the Rapid Diagnosis and Isolation of the Slow-Growing Pathogen Francisella tularensis

MICROBIOLOGY SPECTRUM

IF3.8

2022-10-260

OAAI

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice

IF3.5

2022-07-2613

OAAI

Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague

IF3.5

2022-03-2613

OAAI

An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen Yersinia pestis

诊断性血液培养条件的改善可以快速检测和隔离生长缓慢的病原体鼠疫耶尔森菌

IF3.3

2022-02-162

OAAI

Novel RNA Extraction Method for Dual RNA-seq Analysis of Pathogen and Host in the Early Stages of Yersinia pestis Pulmonary Infection

IF4.2

2021-10-181

OAAI

Improved Selective BIN Agar for a Better Rate of Yersinia pestis Isolation from Primary Clinical Specimens in Suspected Madagascar Plague Cases

改进的选择性BIN琼脂可提高疑似马达加斯加鼠疫病例中主要临床标本的鼠疫耶尔森菌隔离率

JOURNAL OF CLINICAL MICROBIOLOGY

IF5.4

2021-07-196

OAAI

Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of Yersinia pestis for a Rapid Plague Outbreak Response

鼠疫耶尔森菌的基于报告噬菌体的检测和抗生素敏感性测试，以快速应对鼠疫暴发

IF4.2

2021-06-116

OAAI

Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures

IF4.2

2021-05-138

OAAI

Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection

新型单克隆抗F1和抗LcrV抗体的表位结合及其在简单，简短，HTRF试验中用于临床鼠疫检测的应用

IF3.3

2021-03-022

OAAI

Characterization of Yersinia pestis Phage Lytic Activity in Human Whole Blood for the Selection of Efficient Therapeutic Phages

IF3.5

2021-01-1113

OAAI

Screening of an FDA-Approved Library for Novel Drugs against Y. pestis

FDA批准的抗鼠疫耶尔森氏菌新药库的筛选

ANTIBIOTICS-BASEL

IF4.6

2021-01-031

OAAI

A single dose of recombinant VSV-G-spike vaccine provides protection against SARS-CoV-2 challenge

NATURE COMMUNICATIONS

IF15.7

2020-12-16165

OAAI

Yahalom-Ronen, Yfat; Tamir, Hadas; Melamed, Sharon; Politi, Boaz; Shifman, Ohad; Achdout, Hagit; Vitner, Einat B.; Israeli, Ofir; Milrot, Elad; Stein, Dana; Cohen-Gihon, Inbar; Lazar, Shlomi; Gutman, Hila; Glinert, Itai; Cherry, Lilach; Vagima, Yaron; Lazar, Shirley; Weiss, Shay; Ben-Shmuel, Amir; Avraham, Roy; Puni, Reut; Lupu, Edith; Bar-David, Elad; Sittner, Assa; Erez, Noam; Zichel, Ran; Mamroud, Emanuelle; Mazor, Ohad; Levy, Haim; Laskar, Orly; Yitzhaki, Shmuel; Shapira, Shmuel C.; Zvi, Anat; Beth-Din, Adi; Paran, Nir; Israely, Tomer

Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments

SCIENTIFIC REPORTS

IF3.9

2020-11-055

OAAI

Group activity of mice in communal home cage used as an indicator of disease progression and rate of recovery: Effects of LPS and influenza virus

IF5.1

2020-10-013

PREAI

Early Diagnosis of Pathogen Infection by Cell-Based Activation Immunoassay

IF5.2

2019-08-2210

OAAI